Clinical indications for breast MRI

Applied Radiology

Volumn 39, Issue 10, 2010, Pages 10-19

  Argus, Amy ^a   Mahoney, Mary C ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE;

BREAST; BREAST BIOPSY; BREAST CARCINOMA; BREAST ENDOPROSTHESIS; CANCER ADJUVANT THERAPY; CANCER SCREENING; CONTRAST ENHANCEMENT; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; HEALTH CARE COST; HUMAN; MAMMOGRAPHY; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROSTHESIS FAILURE; REVIEW; SENSITIVITY AND SPECIFICITY; SILICONE PROSTHESIS; TREATMENT RESPONSE; UNITED STATES;

EID: 77958198186     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
2. American College of Radiology Practice Guidelines for the Performance of Magnetic Resonance Imaging of the Breast. Available at: http://www.acr.org. Accessed on September 13, 2010.
3. Berg WA, Gutierrez L, Ness Aiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830-849.
4. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468-473.
5. Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with per-cutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180:901-910.
6. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MRI imaging of breast lesions and effect on treatment. Eur J Surg Oncol.2004;30:501-507.
7. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92:32-38.
8. VanGoethem M, Schelfout K, Kersschot E, et al. Enhancing area surrounding breast carcinoma on MR mammography: Comparison with pathological examination. Eur Radiol. 2004;14:1363-1370.
9. Boetes C, Mus RD, Holland R, et al. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995;197:743.
10. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007; 356:1295-1303.
11. Berg WA: Imaging the local extent of disease. Semin Breast Dis. 2001;4:153-173.
12. Hwang ES, Kinkel K, Esserman LI, et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: Value in the diagnosis of residual disease, occult invasion and multicentricity. Ann Surg Oncol. 2003;10:381-388.
13. Kreche KN, Gisvold JJ. Invasive lobular carcinoma of the breast: Mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161:957-960.
14. Mann RM, Hoogeveeri YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: A review of existing literature. Breast Cancer Res Treat. 2008; 107:1-14.
15. Rodenko GN, Harris SE, Prurieda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: Correlation with pathology. AJR Am J Roentgenol. 1996; 167:1415-1419.
16. Dillon MF, Hill AD, Fleming FJ, et al. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma. Am J Surg. 2006;191:201-205.
17. Morris EA, Schwartz LH, Drotman MB, et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: Early experience. Radiology. 2000;214:67-72.
18. Kaufmann M, Von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: Review and recommendations. J Clin Oncol. 2003;21:2600-2608.
19. Yeh E, Slanetz P, Kopans D, et al. Prospective comparison of mammography, sonography and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol. 2005:184;868-877.
20. Partridge S, Gibbs J, Yin L, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002;179: 1193-1199.
21. Belli P, Consantini M, Malaspina C, et al. MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy. Clin Rad. 2006;61:946-953.
22. Chagpar AB, Middleton LP, Sahin AA, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006;243: 257-264.
23. Chen JH, Feig B, Agrawal G, et al. MRI Evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008;112:17-26.
24. Frei KA, Kinkel K, Bonel HM, et al. MR imaging of the breast in patients with positive margins after lumpectomy:Iinfluence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol. 2000;175:1577-1584.
25. Orel SG, Reynolds C, Schnall MD, et al. Breast carcinoma MR imaging before re-excisional biopsy. Radiology. 1997:205;429-439.
26. Lee JM, Orel SG, Czerniecki BJ, et al. MRI before re-excision surgery in patients with breast cancer. AJR Am J Roentgenol. 2004;182:473-480.
27. Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999;212:543-549.
28. Buchanan CL, Morris EA, Doru PL, et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Amer Surg Oncol. 2005;12:1045-1053.
29. Goodman CM, Cohen V, Thornby J, Netscher D. The life span of silicone gel breast implants and a comparison of mammography, ultrasound, and magnetic resonance imaging in detecting implant rupture: A meta-analysis. Ann Plast Surg. 1998;41:577-586.
30. Giovanni DB, Cecchini S, Grassetti L, et al. Comparative study of breast implant rupture using mammography, sonography and magnetic resonance imaging: Correlation with surgical findings. Breast J. 2008;14:532-537.
31. Ikeda DM, Borofsky HB, Gerfkens RJ, et al. Silicone breast implant rupture: Pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography and ultrasound. Plast Reconstr Surg. 1999;104:2054-2062.
32. Cher DJ, Conwell JA, Mandel JS. MRI for detecting silicone breast implant rupture: Meta-analysis and implications. Ann Plast Surg. 2001;47:367-380.
33. Kriege M, Brekelmans CT, Boetes C, et al. Efficiency of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427-437.
34. Bluemke D, Gatsonis C, Chen M, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735-2742.
35. Moy L, Elias K, Patel V, et al. Is breast MRI helpful in the evaluation of inconclusive mammo-graphic findings? AJR Am J Roentgenol. 2009; 193:986-993.